Company Performance Metrics
- Charles Umeadi: Founder & President
Cornell Pharmaceuticals specializes in the manufacturing of pharmaceutical products, focusing on the development and provision of affordable, life-saving medicines primarily targeting cancer treatments. The company emphasizes the importance of accessibility to essential medications in Sub-Saharan Africa, aiming to revolutionize healthcare in the
region. Cornell Pharmaceuticals also offers private consultation services regarding prescription medications, covering usage, potential side effects, and drug interactions. With a commitment to leveraging up-to-date manufacturing practices and technological infrastructure, the company strives for efficient operations. Established in 2013 and based in the United States, Cornell Pharmaceuticals employs 304 individuals dedicated to building a patient-centric world.